19 Recruiting Trials

Clinical Trials
for Alzheimer's in Tennessee

19 clinical trials for Alzheimer's are currently recruiting participants at study sites in Tennessee. Study-related care is provided at no cost.

19
Recruiting trials
22
Study sites
11
Cities
12
Industry-sponsored
7
Phase 2
6
Phase 3

Alzheimer's clinical trials in Tennessee: what to expect

Alzheimer's trials now span the whole course of the disease. Prevention studies enroll people with normal memory who have early signs of amyloid in the brain; treatment studies enroll people with mild cognitive impairment or early Alzheimer's and test the next generation of antibodies, tau-targeting drugs and combinations; and symptom studies address agitation, sleep and depression in later stages. Alongside drugs there are trials of exercise, cognitive training, blood tests for diagnosis and support programs for care partners.

In Tennessee, recruiting alzheimer's studies are concentrated in Nashville, Cordova, Knoxville and Chattanooga, with sites in 7 other cities. 12 of the 19 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who Alzheimer's trials usually look for

Most drug trials enroll ages 50 to 85 and define a stage with a memory test score range, then confirm Alzheimer's with an amyloid PET scan, a spinal fluid test or, increasingly, a blood test, all done by the study. Nearly every trial requires a study partner: someone who knows you well, attends visits and answers questions about daily life. Common exclusions are another cause of memory loss, a recent stroke and, for antibody trials, some blood thinners or MRI findings. Prevention trials enroll people with no symptoms at all.

What taking part involves

Screening is longer than for most conditions, often several visits over a few weeks with memory testing, an MRI and an amyloid test. Antibody trials then involve an infusion or injection every two to four weeks, regular safety MRIs and visits for eighteen months to four years, with an extension in which everyone receives the drug. Lifestyle trials involve classes or coaching for six to twenty-four months. All study care is free and travel is usually reimbursed for you and your partner.

Questions worth asking the study team

Whether you will be told your amyloid or genetic results; what the MRI safety monitoring involves; how much time the study partner must give; whether there is an extension after the placebo period; and what happens if memory worsens during the study.

Showing 19 of 19 recruiting Alzheimer's trials in Tennessee

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
PHASE3 Long Beach, California +4 sites NCT06976216
This trial is looking for people with mild to moderate Alzheimer's disease who want to help test a new treatment. Participants will need a caregiver to support them and attend study visits.
Recruiting
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
PHASE1 Irvine, California +4 sites NCT07599670
This trial is looking for people with Alzheimer's disease to test a new drug called ABBV-1758. Participants will receive injections of the drug or a placebo every 4 weeks for 24 weeks.
Recruiting
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
PHASE3 Birmingham, Alabama +4 sites NCT07177352
This trial is looking for individuals who may qualify for Alzheimer's disease research studies. Participants will be assessed to see if they can join related interventional studies.
Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
PHASE3 Homewood, Alabama +4 sites NCT05980949
This trial is looking for people who have completed previous studies on KarXT for Alzheimer's-related psychosis. Participants will take KarXT for a year to help researchers understand its long-term safety and tolerability.
Recruiting
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
PHASE3 Homewood, Alabama +4 sites NCT05511363
This trial is looking for older adults with psychosis associated with Alzheimer's Disease. Participants will be randomly assigned to receive either KarXT or a placebo for 38 weeks, with regular visits to monitor their condition.
Recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3 Birmingham, Alabama +4 sites NCT07169578
This trial is looking for people with early Alzheimer's disease symptoms. Participants will take part in tests to evaluate their memory and cognitive abilities while receiving treatment.
Recruiting
Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease
PHASE2 Nashville, Tennessee NCT07794670
This trial is looking for adults who might be at risk for Preclinical Alzheimer's Disease. Participants will take a drug called Obicetrapib to see how it affects their condition.
Recruiting
Alzheimer's Tau Platform: Master Protocol
PHASE2 Nashville, Tennessee +2 sites NCT06957418
This trial is looking for adults aged 50-80 with early signs of Alzheimer's disease. Participants will receive a treatment for tau buildup in the brain and will be monitored for 30 months with tests and brain scans.
Recruiting
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
PHASE1 Phoenix, Arizona +4 sites NCT05462106
This trial is looking for adults with early stages of Alzheimer's disease or adults with Down syndrome. Participants will take a study medication and be monitored for safety and effects.
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
PHASE3 Chandler, Arizona +4 sites NCT06585787
This trial is looking for adults aged 55 to 90 who have been diagnosed with Alzheimer's disease and have experienced troubling symptoms like hallucinations or delusions for at least two months. However, if someone has severe mental health issues like schizophrenia or major depression with psychosis, they won’t be eligible to join. They also need to have had a brain scan in the last five years to ensure there aren’t other serious conditions affecting their symptoms.
Recruiting
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
PHASE2 Phoenix, Arizona +4 sites NCT06847321
This trial is looking for people with mild to moderate Alzheimer's who also have a specific infection. Participants will take a daily capsule and attend study visits over 64 weeks.
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
PHASE2 Homewood, Alabama +4 sites NCT06808984
This trial is looking for people with Alzheimer's disease who experience agitation. Participants will take a medication called BMS-986368 and help researchers understand its effects.
Recruiting
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
PHASE2 Nashville, Tennessee NCT05231798
This trial is looking for adults with Down syndrome, aged 18-55, to help understand brain function as they age. Participants will undergo tests to evaluate their cognitive abilities and brain health.
Recruiting
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
PHASE4 Irvine, California +4 sites NCT07633470
This trial is looking for adults aged 50 and older who have been diagnosed with mild to moderate Alzheimer's disease. Participants will take Zunveyl for 12 weeks and will be monitored for safety and side effects.
Recruiting
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
NA Crossville, Tennessee +4 sites NCT07222280
This trial is looking for patients aged 60 to 90 who are currently hospitalized due to cognitive issues, like confusion or encephalopathy. Participants will take a blood test to help doctors identify if they have underlying Alzheimer's disease.
Recruiting
Trial-Ready Cohort-Down Syndrome (TRC-DS)
N/A Phoenix, Arizona +4 sites NCT04165109
This trial is looking for healthy adults with Down syndrome aged 25-55. Participants will be assessed over time through tests and evaluations to help understand Alzheimer's disease in people with Down syndrome.
Recruiting
Swallowing Impairments in Adults With and Without Alzheimer's Disease
N/A Nashville, Tennessee NCT06678100
This trial is looking for adults aged 60 and older, both with and without Alzheimer's disease, to study swallowing abilities. Participants will undergo tests and complete questionnaires to better understand swallowing function.
Recruiting
Tennessee Alzheimer's Project
N/A Nashville, Tennessee NCT05372172
This trial is looking for older adults aged 60 and up who may have Alzheimer's disease, mild cognitive impairment, or are cognitively unimpaired. Participants will be seen each year for assessments and may be referred to other studies related to Alzheimer's research.
Recruiting
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
NA Murfreesboro, Tennessee +2 sites NCT05820919
This trial is looking for nursing home residents aged 50 and older who have Alzheimer's disease or related dementias and are facing sleep problems. Participants will help test a program designed to improve their sleep quality.
Recruiting

Where the Alzheimer's studies are in Tennessee

  • Vanderbilt University Medical Center, Nashville4 trials
  • Neurology Clinic, P.C., Cordova3 trials
  • Genesis Neuroscience Clinic, Knoxville2 trials
  • K2 Medical Research - Nashville, Nashville2 trials
  • Cumberland Medical Center, Crossville1 trial
  • Fort Loudon Medical Center, Lenoir City1 trial

Counts are recruiting studies listing at least one site in Tennessee, from ClinicalTrials.gov, refreshed every two days.

Alzheimer's clinical trials in Tennessee: common questions

How many Alzheimer's clinical trials are recruiting in Tennessee?
TrialFinder currently lists 19 recruiting Alzheimer's clinical trials with study sites in Tennessee. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Alzheimer's clinical trials located in Tennessee?
Study sites for the Alzheimer's trials listed on this page include Nashville, Crossville, Murfreesboro. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Alzheimer's clinical trial in Tennessee?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Alzheimer's trials in Tennessee also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Alzheimer's clinical trial in Tennessee?
Each study sets its own criteria based on age, Alzheimer's diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Do I need an Alzheimer's diagnosis to join a trial?
No. Prevention trials enroll people with normal memory and test them for early amyloid, and many treatment trials accept people with memory concerns who have not been formally diagnosed, then confirm the diagnosis as part of screening.
What is a study partner?
A family member or close friend who attends visits with you and answers questions about memory and daily activities. Nearly every Alzheimer's trial requires one, and their time is usually reimbursed too.
Will I learn my amyloid or APOE results?
Many trials now disclose amyloid status, since it decides eligibility, and explain what it means. Genetic results are disclosed in some trials and not others; ask before you consent.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Alzheimer's trials near you in Tennessee.

Get Matched — Free
No insurance required

Alzheimer's disease trials test amyloid-clearing antibodies, tau inhibitors, lifestyle interventions, and early-detection biomarkers for dementia prevention and treatment.

All Alzheimer's trials →